insights_auto
Why is AGIO down 3,10%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
28,76 USD
arrow_downward
-3,10%(-0,92) 1D
28,76 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 19-ноя., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
29,93 USD
High
30,35 USD
Low
28,71 USD
Mkt. cap
1,72 млд
Avg. vol.
1,18 млн
Volume
590,44 миң
52-wk high
44,07 USD
52-wk low
23,02 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
Open
29,93 USD
High
30,35 USD
Low
28,71 USD
Mkt. cap
1,72 млд
Avg. vol.
1,18 млн
Volume
590,44 миң
52-wk high
44,07 USD
52-wk low
23,02 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
News stories
From web sources and news partners
FOREX.com
·
6 саат мурун
S&P 500 Analysis: SPX Is Going Through One of Its Most Difficult Periods of 2026
FXStreet
·
7 саат мурун
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Traders Union
·
6 саат мурун
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
BigGo Finance
·
4 саат мурун
Chip ETF Eyes Unprecedented Fourth Straight Year of Beating the S&P 500
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc